Skip to Content

AtheroNova Inc

Rating as of

Company Profile

Business Description

AtheroNova Inc is a clinical stage biotech company focused on discovery, research, development and licensing of novel compounds to reduce or regress atherosclerotic plaque deposits. The company's focus on compounds to reduce or eliminate atherosclerotic plaque deposits addresses the most lucrative segments of the multi-billion-dollar prescription drug market: cardiovascular disease and stroke prevention.

2301 Dupont Drive, Suite 525
Irvine, CA, 92612
T +1 949 476-1100
Sector Healthcare
Industry Biotechnology
Most Recent Earnings Sep 30, 2014
Fiscal Year End Dec 31, 2014
Stock Type Distressed
Employees 3